UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management

Pharmacotherapy, 2015-10, Vol.35 (10), p.949-962

2015

Volltextzugriff (PDF)

Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2023-07, Vol.67 (7), p.e0047523

2023

Volltextzugriff (PDF)

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Volltextzugriff (PDF)

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Volltextzugriff (PDF)

Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.593-599

2011

Volltextzugriff (PDF)

Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria

Future microbiology, 2018-07, Vol.13 (9), p.971-983

2018

Volltextzugriff (PDF)

Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15-20 mg/L Suggested by the Vancomycin Consensus Guidelines

Pharmacotherapy, 2011-05, Vol.31 (5), p.441-448

2011

Volltextzugriff (PDF)

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints

Microbiology spectrum, 2022-06, Vol.10 (3), p.e0115822-e0115822

2022

Volltextzugriff (PDF)

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Clinical infectious diseases, 2021-07, Vol.73 (2), p.e445-e454

2021

Volltextzugriff (PDF)

Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.2235-2238

2010

Volltextzugriff (PDF)

The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for Enterobacteriaceae : Let's Not Let Perfect Be the Enemy of Really Good

Journal of clinical microbiology, 2020-03, Vol.58 (4)

2020

Volltextzugriff (PDF)

Making the change to area under the curve–based vancomycin dosing

American journal of health-system pharmacy, 2018-12, Vol.75 (24), p.1986-1995

2018

Volltextzugriff (PDF)

Monoclonals for patients hospitalised with COVID-19

The lancet respiratory medicine, 2022-10, Vol.10 (10), p.928-930

2022

Volltextzugriff (PDF)

Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008–10

Journal of antibiotics, 2013-10, Vol.66 (10), p.625-627

2013

Volltextzugriff (PDF)

EDITORIAL COMMENTARY: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed

Clinical infectious diseases, 2015-05, Vol.60 (9), p.1304-1307

2015

Volltextzugriff (PDF)

Toxicity in Patients

Polymyxin Antibiotics: From Laboratory Bench to Bedside, 2019-01, Vol.1145, p.289-304

2019

Volltextzugriff (PDF)

An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Volltextzugriff (PDF)

Reply to Vena et al

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1801-1802

2020

Volltextzugriff (PDF)

Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis

JAMA internal medicine, 2022-08, Vol.182 (8), p.805

2022

Volltextzugriff (PDF)

Colistin: Understanding and Applying Recent Pharmacokinetic Advances

Pharmacotherapy, 2015-01, Vol.35 (1), p.11-16

2015

Volltextzugriff (PDF)

Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world

Expert opinion on pharmacotherapy, 2019-11, Vol.20 (17), p.2053-2057

2019

Volltextzugriff (PDF)

The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli

Antimicrobial agents and chemotherapy, 2019-03, Vol.63 (3)

2019

Volltextzugriff (PDF)

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2541-2546

2014

Volltextzugriff (PDF)

Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Antimicrobial agents and chemotherapy, 2016-06, Vol.60 (6), p.3743-3750

2016

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(140)

Publikationsform

Sprache

Englisch
(159)

Erscheinungsjahr

n.n

Thema

Science & Technology
(72)
Life Sciences & Biomedicine
(68)
Humans
(48)
Pharmacology & Pharmacy
(27)
Abstracts
(25)
Animals
(23)
Microbiology
(21)
Female
(19)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Male
(16)
Mice
(15)
Anti-Bacterial Agents - Therapeutic Use
(13)
Biological And Medical Sciences
(11)
Colistin
(11)
Medical Sciences
(11)
Aged
(10)
Imaging
(10)
Oncology
(10)
Retrospective Studies
(10)
Anti-Bacterial Agents
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management

Case Commentary: When Voldemort Meets Sauron: Treatment Considerations for Emerging Dual-Carbapenemase-Producing Extensively Drug-Resistant Pseudomonas aeruginosa

A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity

Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)

Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan

Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria

Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15-20 mg/L Suggested by the Vancomycin Consensus Guidelines

A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints

Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19

Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System

The Clinical Impact of a Negative Molecular β-Lactamase Gene Test for Enterobacteriaceae : Let's Not Let Perfect Be the Enemy of Really Good

Making the change to area under the curve–based vancomycin dosing

Monoclonals for patients hospitalised with COVID-19

Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008–10

EDITORIAL COMMENTARY: Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed

Toxicity in Patients

An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities

Reply to Vena et al

Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis

Colistin: Understanding and Applying Recent Pharmacokinetic Advances

Laces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO world

The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli

Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy

Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Aktive Filter

Suchergebnisse filtern